Literature DB >> 18432872

Human natural killer receptors and their ligands.

Roberto Biassoni1, Cristina Bottino, Claudia Cantoni, Alessandro Moretta.   

Abstract

Human Natural Killer Receptors and Their Ligands (Roberto Biassoni and Cristina Bottino, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; Claudia Cantoni, Universita degli Studi di Genova, Istituto Giannina Gaslini, Genova, Italy; Alessandro Moretta, Universita degli Studi di Genova, Genova, Italy). Natural killer (NK) cells are a lymphocyte subpopulation that are important effectors of innate immune responses against infectious pathogens. They are thought to play an important role in host defense, not only against virally infected cells, but also in killing of tumor cells. Recent progress indicates that NK cells express an array of receptors, some of them clonally distributed, able to modulate the natural cytotoxicity. Three NK-specific activating receptors have been characterized; they belong to a novel receptor family called natural cytotoxicity receptors (NCR) and are represented by NKp46, NKp44, and NKp30. These receptors, upon engagement by their specific ligands, induce a strong activation of NK-mediated cytotoxic activity. This overview discusses the receptors (both activating and inhibitory) expressed by NK cells and their ligands. Finally, the dysfunction of one of these molecules occurring in a genetically inherited immunodeficiency is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 18432872     DOI: 10.1002/0471142735.im1410s46

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  11 in total

1.  Low-dose IL-2 induces CD56bright NK regulation of T cells via NKp44 and NKp46.

Authors:  S T Loughran; P A Power; S L McQuaid; P Maguire; A Szczygiel; P A Johnson
Journal:  Clin Exp Immunol       Date:  2020-02-13       Impact factor: 4.330

2.  Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D.

Authors:  Costin Tomescu; Domenico Mavilio; Luis J Montaner
Journal:  AIDS       Date:  2015-09-10       Impact factor: 4.177

3.  Generation and characterization of monoclonal antibodies to equine NKp46.

Authors:  Leela E Noronha; Rebecca M Harman; Bettina Wagner; Douglas F Antczak
Journal:  Vet Immunol Immunopathol       Date:  2012-04-07       Impact factor: 2.046

4.  Cryopreserved NK cells in the treatment of haematological malignancies: preclinical study.

Authors:  Monika Holubova; Michaela Miklikova; Martin Leba; Daniel Georgiev; Pavel Jindra; Martin Caprnda; Rachele Ciccocioppo; Peter Kruzliak; Daniel Lysak
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-10       Impact factor: 4.553

5.  A role for B cells in facilitating defense against an NK cell-sensitive lung metastatic tumor is revealed by stress.

Authors:  Harlan P Jones; Beau Aldridge; Katherine Boss-Williams; Jay M Weiss
Journal:  J Neuroimmunol       Date:  2017-11-03       Impact factor: 3.478

6.  Siglec-7 engagement by GBS β-protein suppresses pyroptotic cell death of natural killer cells.

Authors:  Jerry J Fong; Chih-Ming Tsai; Sudeshna Saha; Victor Nizet; Ajit Varki; Jack D Bui
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-25       Impact factor: 11.205

7.  Cutting Edge: Role of NK Cells and Surfactant Protein D in Dendritic Cell Lymph Node Homing: Effects of Ozone Exposure.

Authors:  Moyar Qing Ge; Blerina Kokalari; Cameron H Flayer; Sarah S Killingbeck; Imre G Redai; Alexander W MacFarlane; Jin W Hwang; Anisha Kolupoti; Michael D Kemeny; Kerry S Campbell; Angela Haczku
Journal:  J Immunol       Date:  2015-12-16       Impact factor: 5.422

Review 8.  The structural basis of ligand recognition by natural killer cell receptors.

Authors:  M Gordon Joyce; Peter D Sun
Journal:  J Biomed Biotechnol       Date:  2011-05-18

9.  Persons who inject drugs (PWID) retain functional NK cells, dendritic cell stimulation, and adaptive immune recall responses despite prolonged opioid use.

Authors:  Costin Tomescu; Krystal Colon; Peter Smith; Mack Taylor; Livio Azzoni; David S Metzger; Luis J Montaner
Journal:  J Leukoc Biol       Date:  2020-12-02       Impact factor: 6.011

Review 10.  Complexity and Diversity of the NKR-P1:Clr (Klrb1:Clec2) Recognition Systems.

Authors:  Christina L Kirkham; James R Carlyle
Journal:  Front Immunol       Date:  2014-06-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.